-
Comparison of Clinical Symptoms Scored According to NIH-CPSI in Patients with Chronic Prostatitis Syndrome Category IIIa and IIIb
-
Jae Young Choi, Moung Jin Lee, Seung Hoon Cho, Sung Bin Kim, Seung Tae Lee, Seung Ki Min
-
Korean J Urogenit Tract Infect Inflamm 2011;6(1):42-47. Published online April 30, 2011
-
-
-
Abstract
PDF
- "Purpose: With little evidence, the causes of inflammatory and non-inflammatory chronic pelvic pain syndrome (CPPS), which cover a majority of cases of prostatitis syndromes, have not been fully explicated. The mechanisms of these two CPPS may be different. Although the clinical symptoms are expected to be disparate, we compared the clinical symptoms between the two using National Institutes of Health chronic prostatitis symptoms index (NIH-CPSI) over several parameters. Materials and Methods: The chronic pelvic pain syndrome patients (n=256) at our institution between April 2009 and March 2010 were included. After classifying these patients into two groups, the inflammatory CPPS and the non-inflammatory CPPS groups, we compared the two groups in terms of pain or discomfort, urinary symptom, quality of life, prostate volume measured by transrectal ultrasonography (TRUS), prostate specific antigen (PSA) and maximum flow rate (Qmax) difference. Result: There was no statistically significant difference between the two groups in pain or discomfort, urinary symptom, quality of life, prostate volume measured by TRUS, and Qmax difference. However, inflammatory CPPS patients showed meaningfully higher PSA scores than non-inflammatory CPPS patients. No significant difference was observed between patient age and compared among the age groups. Pain or discomfort, urinary symptom, quality of life, prostate volume measured by TRUS, and Qmax difference within each age group were not significantly different between the inflammatory CPPS & non-inflammatory groups. Conclusions: There was no statistically significant difference between the two groups except PSA. It remains unreliable to distinguish inflammatory CPPS from non-inflammatory CPPS based solely on clinical symptoms."
-
Urinary Candidiasis Caused by Fluconazole-Resistant Candida glabrata
-
Moung Jin Lee, Seung Hoon Cho, Jae Young Choi, Seung Tae Lee, Seung Ki Min
-
Korean J Urogenit Tract Infect Inflamm 2010;5(1):97-101. Published online April 30, 2010
-
-
-
Abstract
PDF
- Urinary tract infection caused by Candida glabrata is an uncommon fungal infection. Risk factors for candiduria include diabetes mellitus, antimicrobial use, immunosuppressive therapy and urinary tract defect. We recently experienced a case of urinary tract infection caused by fluconazole-resistant Candida glabrata in a 57-year old woman with diabetes. The diagnosis and management are discussed, and the literature is reviewed
-
Significance of Pyospermia in the Patients with Varicocele
-
Moung Jin Lee, Seung Hoon Cho, Jong Wan Lim, Seung Tae Lee, Seung Ki Min
-
Korean J Urogenit Tract Infect Inflamm 2009;4(2):196-201. Published online October 31, 2009
-
-
-
Abstract
PDF
- "Purpose: Pain is one of the indications to treat varococele at any age. The purpose of this study is to find the significance of pyospermia in the patients surgically treated for scrotal pain associated with varicocele. Material and Methods: From January 2002 to December 2008, a total of 365 men underwent varicocelectomy. As the preoperative semen analysis, we classified patients of scrotal pain into two groups as pyospermia group I (N=136) and non-pyospermia group II (N=112). Preoperative and postoperative clinical symptoms were analyzed. The result was classified into completely resolved, partially resolved and unchanged based on the relief of pain. Results: Of 365 men, 248 (67.95%) patients were available for follow-up 3 months postoperatively. Among 119 patients with scrotal pain who have received the varicocelectomy, 42 (65.63%) and 5 (7.8%) patients in group I (64 patients) reported completely resolved and partially resolved respectively (mean response rate 73.44%). In group II (55 patients), 42 (76.36%) and 8 (14.55%) reported completely and partially resolved respectively (mean response rate 90.90%) (p<0.05). Seventeen and 5 patients in group I and II reported persistent pain, respectively. Conclusions: Patients with pyospermia surgically treated for scrotal pain associated with varicocele have tendency to have persistent pain after surgical treatment. This result may help the varicocele patients with persistent pain after receiving the surgery."
-
Is the Prophylactic Intravenous Antibiotics before the Prostate Biopsy Effective?
-
Jong Wan Lim, Moung Jin Lee, Seung Hoon Cho, Seung Ki Min
-
Korean J Urogenit Tract Infect Inflamm 2009;4(1):56-61. Published online April 30, 2009
-
-
-
Abstract
PDF
- "Purpose: The blood serum prostate-specific antigen (PSA) and digital rectal examination (DRE) are being more commonly used for the early diagnosis of prostate cancer, such that more patients are going through prostate biopsies. The authors investigated the value of prophylactic intravenous antibiotics to prevent infective complication after the biopsy. Materials and Methods: The subjects were 356 patients aged 40-88 year who had a prostate biopsy from January 2004 to July 2008. Among them, 89 patients who had taken prophylactic intravenous antibiotics before the biopsy were designated as Group I, and the remaining 267 patients, as Group II who didn't had taken prophylactic intravenous antibiotics before the biopsy. The patients took then oral antibiotics (fluoroquinolone) for one week, from the morning after the biopsy, to prevent infection. The occurrence of complication was monitored based on such symptoms as gross hematuria, rectal bleeding, hemospermia, dysuria, voiding difficulty, fever. Results: 87 patients (24.4%) of the total 356 patients were diagnosed with prostate cancer. Infective complication occurred in 6 patients (1.7%), among whom 2 patients (2.2%) in Group I had taken prophylactic intravenous antibiotics, and 4 patients (1.6%) in Group II did not take intravenous antibiotics. Infective complication rates of the two groups did not have statistically differences (p>0.05). Conclusions: The intake of prophylactic intravenous antibiotics before the prostate biopsy did not have a special impact on the prevalence rate of infective complication after the biopsies."
-
Idiopathic Retroperitoneal Fibrosis: Clinical Role of 18F-Fluorodeoxyglucose Positron Emission Tomography for Differential Diagnosis from Malignancy
-
Chang Seung Liu, Seung Hun Seol, Jong Wan Im, Moung Jin Lee, Yeon Won Park, Seung Ki Min
-
Korean J Urogenit Tract Infect Inflamm 2008;3(1):108-115. Published online April 30, 2008
-
-
-
Abstract
PDF
- Retroperitoneal fibrosis sometimes causes urological problem involving the ureter, but the mechanism is uncertain. The most common treatment of retroperitoneal fibrosis is often a surgical exploration followed by urologic intervention, but medical therapy has been advocated recently. For medical therapy, there is necessary to exclude malignancy and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) scan may be an useful alternative tool to avoid invasive procedure including open biopsy. Here we report two patients who were undergone the FDG-PET scan to exclude malignancy and received successful treatment of retroperitoneal fibrosis with prednisolone.
|